Award
NIH Reporter #1R34AI198088-01
Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial
Recipient
UNIVERSITY OF ROCHESTER
Award Amount
$151,572.00
Ceiling
$151,572.00
Awarded
August 27, 2026
Identifier
1R34AI198088-01
A NIH-funded phase III randomized controlled trial testing aggressive antipyretic therapy to reduce mortality and neurological morbidity in pediatric CNS malaria.
Description
This project involves a phase III, randomized controlled trial of adjunctive aggressive antipyretic therapy for pediatric CNS malaria, aiming to reduce mortality and neurological morbidity. The project is funded by NIH and involves international collaboration in Malawi, Zambia, and DRC.